Primary Cisplatin, Methotrexate and Vinblastine Chemotherapy With Selective Bladder Preservation for Muscle Invasive Carcinoma of the Bladder: Long-Term Followup of a Prospective Study
- 1 June 2002
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 167 (6) , 2413-2418
- https://doi.org/10.1016/s0022-5347(05)64995-6
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Phase I-II Study of Paclitaxel, Cisplatin, and Gemcitabine in Advanced Transitional-Cell Carcinoma of the UrotheliumJournal of Clinical Oncology, 2000
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome.Journal of Clinical Oncology, 1998
- FEASIBILITY OF TRANSURETHRAL RESECTION FOR MUSCLE INFILTRATING CARCINOMA OF THE BLADDER: LONG-TERM FOLLOWUP OF A PROSPECTIVE STUDYJournal of Urology, 1998
- Conservative management of stage T2 or T3a bladder cancer with deep transurethral resection followed by four cycles of chemotherapyBritish Journal of Urology, 1996
- Primary Methotrexate, Vinblastine, Doxorubicin and Cisplatin Chemotherapy and Bladder Preservation in Locally Invasive Bladder Cancer: A 5-Year FollowupJournal of Urology, 1994
- CMV front-line chemotherapy in transitional bladder carcinomaAnnals of Oncology, 1993
- Conservative Management of Muscle-Infiltrating Bladder Cancer: Prospective ExperienceJournal of Urology, 1987
- A Network Algorithm for Performing Fisher's Exact Test in r × c Contingency TablesJournal of the American Statistical Association, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958